Testing a lab-made blood vessel for heart bypass surgery
Part of Heart & circulation clinical trials.
This trial tests a man-made blood vessel (CTEV) as a new option for bypass grafts in people who need heart bypass surgery. It aims to see if the CTEV is safe and effective for improving blood flow to the heart.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older and planning your first heart bypass surgery.
- The bypass must include a graft to the left front artery (LAD) and at least one other blocked artery.
- The artery to be bypassed with the study vessel must be at least 70% blocked (or have reduced blood flow) and be a certain size.
- You cannot have had a heart attack in the last 7 days or be in unstable condition.
- You cannot have had previous heart surgery or need another heart procedure at the same time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a lab-made blood vessel (called an ATEV) used as a bypass graft during heart surgery. The ATEV is designed for people who don't have enough healthy leg vein for standard bypass grafts, and it may help restore blood flow to the heart more safely.
This trial tests a new artificial blood vessel for heart bypass surgery. If you need a bypass and meet the health requirements, you may be able to receive this experimental graft.
This trial tests a new device called the VentriCure that helps the heart pump blood. It is for people with severe coronary artery disease and a weak heart who cannot have bypass surgery or choose not to.
This trial tests whether transplanting tiny heart “micrografts” from the left heart chamber area can improve heart function after cardiac surgery. It is meant for people with weakened heart pumping and heart failure symptoms despite medicine.
This study compares two surgical techniques for heart bypass: using the left internal thoracic artery in one specific way versus another. It may help improve how well the bypass works in people who need bypass surgery for multiple blocked heart arteries.
This trial tests whether a blood-thinner drug called cangrelor helps patients who are having a special type of bypass surgery that uses a small incision instead of opening the whole chest. The surgery connects a healthy artery from your chest wall directly to a blocked heart vessel to restore blood flow.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.